Constitutive nuclear factor (NF)-jB activation in haematological malignancies is caused in several cases by loss of function mutations within the coding sequence of NF-jB inhibitory molecules such as IjBa or p100. Hut-78, a truncated form of p100, constitutively generates p52 and contributes to the development of T-cell lymphomas but the molecular mechanism underlying this oncogenic potential remains unclear. We show here that MMP9 gene expression is induced through the alternative NF-jB-activating pathway in fibroblasts and also on Hut-78 or p52 overexpression in fibroblasts as well as in lymphoma cells. p52 is critical for Hut-78-mediated MMP9 gene induction as a Hut-78 mutant as well as other truncated NF-jB2 proteins that are not processed into p52 failed to induce the expression of this metalloproteinase. Conversely, MMP9 gene expression is impaired in p52-depleted HUT-78 cells. Interestingly, MLL1 and MLL2 H3K4 methyltransferase complexes are tethered by p52 on the MMP9 but not on the IjBa promoter, and the H3K4 trimethyltransferase activity recruited on the MMP9 promoter is impaired in p52-depleted HUT-78 cells. Moreover, MLL1 and MLL2 are associated with Hut-78 in a native chromatin-enriched extract. Thus, we identified a molecular mechanism by which the recruitment of a H3K4 histone methyltransferase complex on the promoter of a NF-jB-dependent gene induces its expression and potentially the invasive potential of lymphoma cells harbouring constitutive activity of the alternative NF-jB-activating pathway.
Introduction
Most haematological disorders remarkably share a constitutive nuclear factor (NF)-kB activity (Karin and Lin, 2002; Courtois and Gilmore, 2006; Keutgens et al., 2006; Jost and Ruland, 2007; Perkins, 2007) . NF-kB is a latent cytoplasmic transcription factor whose activation is regulated via control of nuclear translocation through the signal-induced degradation of inhibitory proteins (Hayden and Ghosh, 2008) . Two main NF-kB-activating signalling pathways have been characterized and referred to as the 'classical' or 'canonical' pathway and the 'alternative' or 'non-canonical' pathway (Bonizzi and Karin, 2004) . The classical pathway, which is triggered by cytokines such as tumor necrosis factor-a (TNFa), interleukin (IL)-1b, or by the ligand for the T-cell or B-cell receptor, leads to IkBa degradation and subsequent nuclear import of the p50/p65 heterodimer through a NEMO/IKKg-dependent pathway (Li and Verma, 2002; Shim et al., 2005) . The alternative pathway, which is triggered by cytokines such as lymphotoxin-b (LTb), BAFF and CD40, relies on the NIK-and IKKa-mediated phosphorylation and processing of the inhibitory protein p100 into p52. As a result, a p52/RelB heterodimer moves into the nucleus and induces the expression of proteins involved in lymphoid organogenesis and B-cell homeostasis (Claudio et al., 2002; Coope et al., 2002; Dejardin et al., 2002) .
NF-kB acts as a survival factor from early lymphopoiesis to later stage of development and maturation of B and T cells (Siebenlist et al., 2005) . The constitutive NF-kB activity seen in most haematological disorders occurs through several mechanisms, including the chromosomal translocation and subsequent overexpression of BCL-3 in a subset of human B-cell chronic lymphotic leukaemias (McKeithan et al., 1987) and mutations of the IkBa gene that impair its inhibitory function in some cases of Hodgkin's lymphomas (Cabannes et al., 1999; Emmerich et al., 1999; Jungnickel et al., 2000) . Gene amplification of NIK or loss of function mutations for inhibitory signalling molecules such as TRAF3 and CYLD have been reported in multiple myelomas (Annunziata et al., 2007; Keats et al., 2007) .
Rearrangement of the nf-kb2 gene has been described in some cutaneous T-cell lymphomas, B-cell chronic lymphocytic leukemias (CLLs), multiple myelomas and B-cell lymphomas (Keutgens et al., 2006) . These translocations cause the expression of truncated p100 proteins referred to as Lyt-10-Ca, LB40 or Hut-78/p85/ p80HT, that differ in their C-terminal end (Neri et al., 1991; Fracchiolla et al., 1993; Thakur et al., 1994) . Those proteins are nuclear and constitutively generate p52 because of the loss of the C-terminal processinginhibitory domain of p100 (Zhang et al., 1994; Chang et al., 1995; Xiao et al., 2001) . Mice with a homozygous deletion of the C-terminal ankyrin repeats of p100, which allows them to express p52 but not the inhibitory protein p100, suffered from gastric hyperplasia and also showed enlarged lymph nodes and increased proliferation of peripheral lymphocytes (Ishikawa et al., 1997) . Interestingly, a transgenic mouse overexpressing a lymphoma-associated NF-kB2 mutant Hut-78 in lymphocytes developed small B-cell lymphomas, in part through the upregulation of the antiapoptotic protein TRAF1 (Zhang et al., 2007) .
The progression of T-cell lymphoma towards a metastatic phenotype is associated with the upregulation of MMP9, which plays key roles in degradation of extracellular matrix and in vascular remodelling (Lalancette et al., 2000; Heissig et al., 2003) . MMP9 is also critical for B-CLL invasion and progression and has been defined as a prognostic factor in patients with nonHodgkin's lymphoma (Sakata et al., 2004; RedondoMunoz et al., 2006) . The transcriptional induction of MMP9 is regulated by NF-kB in HTLV-I-or in Epstein-Barr virus-infected cells (Yoshizaki et al., 1998; Mori et al., 2002) as well as on TNFa stimulation in skeletal muscle cells (Srivastava et al., 2007) . Although the classical, TAK1-and IKKb-dependent NF-kB-activating pathway is required for the TNFamediated MMP9 gene expression (Srivastava et al., 2007) , it is unclear whether the alternative NF-kBactivating pathway is also involved in induction of MMP9 in lymphoma cells.
Here we demonstrate that the constitutively activated alternative NF-kB signalling pathway contribute to the invasive potential of lymphoma cells through induction of MMP9 gene expression by tethering selected H3K4 methyltransferases in a promoter-specific manner.
Results
Induction of MMP9 expression on p52 or Hut-78 overexpression in transformed fibroblasts and in lymphoma cells To gain insight into the mechanisms underlying the oncogenic potential of the truncated NF-kB2 precursors, we overexpressed p52 or Hut-78 in NIH3T3 cells through retroviral infections (Figure 1a) , performed microarray analysis and noticed that MMP9 was the most strongly induced candidate (Figure 1b) . IkBa gene expression remained unchanged (data not shown) and this candidate will be used as control for the subsequent experiments. These data were confirmed by Real-time PCR analysis. Indeed, MMP9 but not IkBa gene expression was induced on p52 or Hut-78 overexpression in NIH3T3 cells (Figure 1c) . Although IkBa expression on p52 or Hut-78 overexpression remained unchanged, it was dramatically induced on TNFa stimulation in control NIH3T3 cells (Figure 1d ). MMP9 activity was also induced as the gelatinase activities of both p52 and Hut-78 overexpressing NIH3T3 cells were enhanced compared to the ones from control or NIH3T3 cells overexpressing p100HB, another truncated p100 protein (Derudder et al., 2003) which barely processes into p52 (Figure 1e , top panel, compare lanes 2 and 3 with lanes 1 and 4, respectively). Thus, MMP9 is a target gene of Hut-78 and p52 in immortalized fibroblasts. We next compared the ability of two other truncated p100 proteins, LB40 and p100HB, to induce the expression of this target gene. Although MMP9 was also strongly induced in NIH3T3 cells overexpressing the p52-producing LB40 oncogenic protein, p100HB did not induce MMP9 in those cells (Figures 2a and b) . We next generated a Hut-78 mutant that failed to generate p52 because of the deletion of the glycine-rich region (GRR) domain ('Hut-78DGRR'; Figure 2c , bottom panel, lane 5) and tested its ability to drive MMP9 expression in NIH3T3 cells. This target gene was weakly induced in those cells (Figure 2d ), indicating that MMP9 transcriptional induction occurs through p52 overproduction. Importantly, the GRR domain of p52 was required for MMP9 gene induction as a p52 mutant lacking this region ('p52 DGRR'; Figure 2c , bottom panel, lane 3) failed to induce this target gene (Figure 2d ). Thus, MMP9 gene induction by the truncated p100 proteins requires both their processing into p52 and the GRR domain.
To determine whether Hut-78-mediated MMP9 gene induction also applies to lymphoma cells, we overexpressed Hut-78 in the lymphoma-derived cell line 164T2. RelB and p50 levels remained similar to the ones detected in control cells and only Hut-78 and p52 were overexpressed ( Figure 3a , top panel, compare lanes 1 and 2). There again, Hut-78 overexpression induced MMP9 but not IkBa at the mRNA level (Figure 3b ). We next depleted p100/p52 through RNA interference in HUT-78 cells and addressed MMP9 mRNA levels in those lymphoma cells (Figure 3c , second panel from the top, compare lanes 1 and 3 with lanes 2 and 4). MMP9 mRNA levels were decreased in those p52-depleted HUT-78 cells (Figure 3d ). We also looked at IkBa protein levels and noticed that this product accumulated in those p52-depleted cells, which indicates that p52 may be required to repress the expression of IkBa in HUT-78 cells (Figure 3c , top panel). p52 depletion in HUT-78 cells also impaired their gelatinase activities, as evidenced by zymogram experiments (Figure 3e on the left, compare lanes 1, 3 and 5 with lanes 2, 4 and 6, respectively). Importantly, MMP9 but not MMP2 protease activity was impaired on p52 depletion in HUT-78 cells (Figure 3e , on the left, top and bottom panels), which is in agreement with our microarray results. The invasive potential of the p52-depleted HUT-78 cells was also impaired, as evidenced by Matrigel invasion assays ( Figure 3e on the right). Thus, our results demonstrate that MMP9 is a p52-and Hut-78-dependent target gene in both transformed fibroblasts and in lymphoma-derived cells and define Total RNAs from NIH3T3 cells infected with empty pBabe, the p52 or Hut-78 expressing viruses were subjected to quantitative real-time PCR analysis to assess IkBa or MMP9 mRNA levels using the appropriate primers. The abundance of the IkBa or MMP9 mRNA levels in NIH3T3 cells infected with the empty virus was set to 1 and levels of both transcripts in p52 or Hut-78 overexpressing NIHT3 cells were relative to that after normalization with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The figure shows the data from six independent experiments performed on two distinct infections (mean values±s.d.). (d) Induction of IkBa expression on tumor necrosis factor-a (TNFa) stimulation but not on p52 overexpression in NIH3T3 cells. NIH3T3 infected with pBabe or with the p52 expressing retrovirus were left untreated or stimulated with TNFa for the indicated periods of time and the abundance of the IkBa mRNA levels was assessed by Real-Time PCR analysis. IkBa mRNA levels in untreated NIH3T3 cells infected with pBabe were set to 1 and levels of this transcript in the other experimental conditions were relative to that after normalization with GAPDH. The figure shows the data from two independent experiments performed in duplicates (mean values±s.d.) . (e) p52 or Hut-78 overexpression in NIH3T3 cells enhances their gelatinase activities. NIH3T3 cells were infected with the indicated retrovirus and zymograms were carried out using the supernatant from the infected cells (upper panel). An anti-p100 western blot was performed using cell extracts from these infected NIH3T3 cells (bottom panel).
p52 as a key molecule for the invasive potential of lymphoma-derived cells harbouring enhanced NF-kB activity.
MMP9 induction via both the classical and the alternative NF-kB-activating pathways
To explore whether the alternative NF-kB-activating pathway, which mainly relies on the p52/RelB heterodimer, drives MMP9 expression, we first stimulated mouse embryonic fibroblast (MEF) cells with a LTbR agonistic antibody, which is known to trigger both the classical and the alternative NF-kB-activating pathways (Dejardin et al., 2002) . As control, we stimulated those cells with TNFa. As expected, the LTbR agonistic antibody, but not TNFa, induced p100 processing into p52 ( At the bottom, cell extracts from NIH3T3 cells infected with the indicated retrovirus were subjected to anti-p100 and anti-b-actin western blots. (b) Overexpression of both Hut-78 and LB40 but not p100HB triggers MMP9 gene expression. Total RNAs from NIH3T3 cells infected with the indicated retrovirus were subjected to Real-Time PCR to assess MMP9 and IkBa expressions. MMP9 and IkBa mRNA levels in NIH3T3 cells infected with pBabe were set to 1 and levels of these transcripts in the other experimental conditions were relative to that after normalization with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The figure shows the data from three independent experiments performed in duplicates (mean values ± s.d.). (c and d) MMP9 induction in NIH3T3 cells requires p52 overproduction and the GRR domain of p52. C. On the top, schematic representation of both Hut-78 and p52 proteins and a Hut-78 mutant that failed to generate p52 because of the deletion of GRR domain ('Hut-78 DGRR'). The p52 DGRR mutant is represented as well. At the bottom, cell extracts from NIH3T3 cells infected with the indicated retrovirus constructs were subjected to anti-p100 and anti-b-actin western blot analysis. (d) Overexpression of the Hut-78 DGRR mutant does not trigger MMP9 gene expression. Total RNAs from NIH3T3 cells infected with pBabe, p52, Hut-78 or with the Hut-78 DGRR or the p52 DGRR constructs were subjected to real-time PCR to assess MMP9 and IkBa expressions. MMP9 and IkBa mRNA levels in NIH3T3 cells infected with pBabe were set to 1 and levels of these transcripts in the other experimental conditions were relative to that after normalization with GAPDH. The figure shows the data from three independent experiments performed in duplicates (mean values±s.d.).
expected, LTb, but not TNFa, triggered p100 processing into p52 in these NEMO-deficient cells (Figure 4b , top panel, compare lane 1 with lanes 2-7), which confirmed that the NF-kB-alternative pathway is still functional in these cells. We observed that TNFa but not LTbmediated MMP9 and IkBa inductions of gene expression were severely impaired in the NEMO-deficient MEFs (Figures 4c and d) . Thus, our data suggest that MMP9 gene expression is regulated by the alternative NF-kB-activating pathway in MEF cells. Hut-78 expression plasmid (lanes 1 and 2, respectively) were subjected to western blot experiments using the anti-p100, anti-RelB, p50 or b-actin, as indicated. (b) Increased MMP9 but not IkBa mRNA levels on Hut-78 overexpression in 164T2 cells. MMP9 and IkBa mRNA levels using total RNAs from both Hut-78 expressing or control 164T2 cells were quantified by real-time PCR analysis. The figure shows the data from two independent experiments performed in duplicates and plotted as described above (mean values±s.d.).
(c) Establishment of p52-depleted HUT-78 cells. HUT-78 cells were infected with the indicated shRNA lentiviral construct and cell extracts from these infected cells were subjected to anti-IkBa, anti-p100 and b-actin western blot analysis. The figure shows the data obtained from two independent infections. (d) Decreased MMP9 mRNA levels on p52 depletion in HUT-78 cells. MMP9 mRNA levels using total RNAs from HUT-78 cells infected with the control or with the shRNA p52 lentiviral construct were quantified by real-time PCR analysis. MMP9 mRNA levels in HUT-78 cells infected with the control shRNA was set to 1 and levels of these transcripts in the other experimental condition were relative to that after normalization with 18S. The figure shows the data from five independent experiments performed in duplicates (mean values ± s.d.). (e) Impaired gelatinase activity and invasive potential in p52-depleted HUT-78 cells. On the left, conditional media from HUT-78 cells infected with the control shRNA or with the shRNA p52 for 24 or 48 h (top and bottom panels, respectively) were subjected to zymogram experiments using a SDS-polyacrylamide gel copolymerized with gelatine. The upper and lower bands correspond to MMP9 and MMP2 activities, respectively. On the right, HUT-78 infected with the indicated shRNA constructs were subjected to Matrigel invasion assays and the number of migrating cells was plotted. The Immunofluorescence studies indicated that Hut-78 and p52 were nuclear whereas p100 was cytoplasmic ( Figure 5b , top panels). A nuclear localization signal (NLS; RKRRK, amino acids 337-341) was identified within its Rel homology domain (RHD; Figure 5a ; Neri et al., 1991) . To prove the role of this sequence for the nuclear localization of Hut-78, we generated from one ('NLS 1' to 'NLS 5') to 4 amino-acid substitutions (NLS 1,2,3,4) within this NLS sequence and addressed the mRNA levels using the appropriate primers. The abundance of the IkBa or MMP9 mRNA levels in unstimulated cells was set to 1 and levels of both transcripts in TNFa or LTb-stimulated cells were relative to that after normalization with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The figure shows the data from three independent experiments (mean values ± s.d.).
localization of the resulting mutants by immunofluorescence. Although amino acids 337 and 341 were dispensable for the nuclear localization of Hut-78 as both the 'NLS1' and 'NLS5' mutants were mostly nuclear, amino acids 338 or 339 were essential as both 'NLS 2' and 'NLS 3' mutants were mostly cytoplasmic (Figure 5b ). Such staining was even more dramatic with the 'NLS 1,2,3,4' mutant where amino acids 337-340 were substituted to alanine (Figure 5b ). Mutation of this NLS did not prevent the constitutive processing into p52 (Figure 5c, compare lanes 2 and 3) . Thus, the nuclear localization of Hut-78 requires the NLS sequence located within the RHD. We next selected and tested several nuclear NF-kB proteins that harbour a transactivating domain for interaction with Hut-78. p65 and RelB bound this truncated NFkB2 protein in HUT-78 cells (Figure 5d , top panel, lanes 3 and 4, respectively). Hut-78 was also found in the anti-p50 immunoprecipitate (Figure 5d , top panel, lane 2). Moreover, ectopically expressed FLAG-Hut-78 also bound overexpressed BCL-3, another oncogenic member of the IkB family that harbours two transactivation domains (Bours et al., 1993;  Figure 5e, top panel, lane 3) . Thus, Hut-78 interacts with multiple NF-kB proteins as well as HDAC proteins (see Supplementary Data section) in the nucleus.
p52 and Hut-78-mediated MMP9 transcriptional induction involves the recruitment of a H3K4 HMT complex Covalent modifications of histones control chromatin structure and regulate gene expression (Shilatifard, 2006; Berger, 2007; Bhaumik et al., 2007) . Histone 
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Figure 5 Hut-78 interacts with multiple nuclear factor (NF)-kB proteins and requires a functional NLS located within the RHD domain for its nuclear localization. (a) Schematic representation of wild-type NF-kB2/p100, Hut-78 and of Hut-78 mutants harbouring from 1 ('NLS 1' to 'NLS 5') to 4 lysine to alanine substitutions ('NLS 1234') within the nuclear localization sequence ('NLS'). RHD, Rel homology domain; PID, processing inhibitory domain; DD, death domain. (b) Hut-78 is a nuclear protein and harbours a functional NLS sequence. HeLa cells were transfected with 2 mg of the indicated expression vectors and analysed by immunofluorescence using an antiserum recognizing the N-terminal peptide of NF-kB2/p100 as primary antibody and fluorescein isothiocyanate (FITC)-conjugated anti-mouse IG as secondary antibody. (c) Constitutive processing of Hut-78, Hut-78 NLS 1234 and of the K75A mutant into p52. 293 cells were transfected with the indicated expression plasmids and an anti-p100 western blot was carried out on the cell extracts. (d) Hut-78 binds to multiple NF-kB proteins. Cell extracts from HUT-78 cells were subjected to anti-HA (negative control), -p50, -p65 or -RelB immunoprecipitations followed by anti-p100 western analysis (top panel, lanes 1-4, respectively). Cell extracts were also subjected to anti-p100, -p50, -p65 or -RelB analysis as well (bottom panels). (e) Hut-78 binds BCL-3. 293 cells were transfected with the indicated expression plasmids and anti-HA (negative control) or anti-BCL-3 immunoprecipitations followed by anti-p100 western analysis were carried out on the cell extracts, as indicated (top panel). Cell extracts were subjected to anti-p100 and anti-BCL-3 western analysis as well (bottom panels).
Involvement of MLL1 and MLL2 in Hut-78-mediated MMP9 gene induction I Robert et al lysine methylation is involved in both gene activation and repression, depending on the identity of the lysine residue targeted for methylation. As di-and trimethylation at histone H3 lysine 4 are correlated with gene activation (Noma and Grewal, 2002; Santos-Rosa et al., 2002) , we determined whether histone H3 was trimethylated at lysine 4 on the kB site of the MMP9 promoter on p52 or Hut-78 overexpression by chromatin immunoprecipitation (ChIP) assays. A robust histone H3K4 trimethylation was detected on the MMP9 but not on the IkBa promoter on p52 or Hut-78 overexpression in NIH3T3 cells (Figure 6b ). This recruitment relies on p52 production as a much weaker H3K4 histone methyltransferase (HMT) activity was detected on the MMP9 promoter in cells expressing the Hut-78 DGRR mutant (Figure 6b) . Finally, the H3K4me3 activity on the MMP9 promoter was impaired on p52 depletion in HUT-78 cells (Figure 6c) . Thus, overexpressed p52 and Hut-78 induce MMP9 expression by tethering a H3K4 HMT complex. Whereas one multi-subunit complex (referred to as COMPASS and Set1 complex) that includes the Drosophila trithorax-related protein Set1 has been shown to trigger the mono-, di-and trimethylation of histone H3K4 in yeast (Briggs et al., 2001; Miller et al., 2001; Nagy et al., 2002; Noma and Grewal, 2002) , multiple complexes harbouring robust H3K4 HMT activities have been isolated in mammalian cells and all of them contained one or two SET domain-containing homologues of yeast Set1 (Hughes et al., 2004; Glaser et al., 2006) . As those distinct Set-1-like human H3K4 HMT complexes also share common subunits such as ASH2L, RBBP5 and WDR5, we determined whether those proteins interact with p52 by coimmunoprecipitation experiments. ASH2L bound p52, although not as strongly as BCL-3 did (used as a positive control; Figure 6d , top panel on the left, lanes 4 and 1, respectively). In contrast to ASH2L, both RBBP5 and WDR5 did not associate with p52 (Figure 6d , top panels on the middle and the right, compare lanes 2 with lanes 4). To explore whether Hut-78 is associated with some ASH2L-containing H3K4 HMTs at the endogenous level, we reasoned that those proteins presumably interacted in the chromatin. This was supported by the nuclear colocalization of Hut-78 but not of Hut-78 NLS 1234 with ASH2L (Figure 6e , panels on the right). We isolated the chromatin-associated proteins from HUT-78 cells, performed anti-ASH2L, -MLL1 and -MLL2 immunoprecipitations and noticed that Hut-78 bound ASH2L, MLL2 and to a less extent MLL1 (Figure 6f,  lanes 2, 4 and 3, respectively) . Thus, our data demonstrate that Hut-78 interacts with some H3K4 HMT complexes in the chromatin of HUT-78 cells.
To explore whether those H3K4 HMTs are recruited by p52 on the MMP9 promoter, we investigated MLL1 and MLL2 (also named KMT2A and KMT2B, respectively; Allis et al., 2007) recruitments to this p52-regulated target gene by ChIP assays. Although we did not detect their recruitment on the IkBa promoter, both MLL1 and MLL2 proteins were tethered on the MMP9 promoter in p52 overexpressing NIH3T3 cells (Figure 6g) . Thus, our data suggest that p52 recruits the H3K4 HMT MLL1 and MLL2 complexes in a gene-specific manner.
Discussion
The NF-kB2 translocation ultimately causes the loss of the inhibitory function of p100 and also p52 overproduction. Although there is now experimental evidence for a key role of this chromosomal translocation in lymphomagenesis (Zhang et al., 2007) , it remained unclear whether the loss of the inhibitory function of p100 and/or the overproduction of p52 is the underlying mechanism. There are several evidences for p52 being essential for the oncogenic potential of the truncated NF-kB2 proteins. First, p52 and a truncated p100 mutant that constitutively produces p52 are oncogenic in vitro, as judged by colony-formation assays performed in rat embryonic fibroblasts or in mouse FL5.12 cells (Qing et al., 2007) . These data suggest that p52 overproduction is sufficient to trigger a transformation anchorage-independent growth in those cells and this was further supported by the very similar expression profile of many tumour-associated genes on overexpression of either p52 or the truncated p100 product (Qing et al., 2007) . Our data support the notion that many tumour-associated genes are induced by the NF-kB2 truncated proteins via p52 production as MMP9 is similarly induced by p52 or Hut-78 but not by a mutant defective in processing. Nevertheless, other data challenged the notion that p52 overproduction alone drives lymphomagenesis. Indeed, constitutive production of p52 in lymphocytes is not tumorigenic in mice but rather predisposed to an inflammatory autoimmune disease through a sustained repression of Bim, a member of the antiapoptotic Bcl-2 family (Wang et al., 2008) . In contrast to Hut-78, overexpressed p52 only transiently induced TRAF1 expression in lymphocytes and rather appeared to act as homodimers harbouring repressing transcriptional activities in vitro and in vivo (Wang et al., 2008) . Those data are in agreement with earlier studies showing that Hut-78 harboured an enhanced transactivation potential compared to p52 (Chang et al., 1995; Epinat et al., 2000; Kim et al., 2000) . Thus, overproduced p52 in lymphocytes triggers the expression of many common target genes, among which is MMP9, yet several genes such as TRAF1 required to drive lymphomagenesis in vivo are specifically induced by Hut-78 but not by p52.
The enhanced MMP9 expression seen on p52 overproduction highlights the fact that the constitutively activated alternative NF-kB pathway contributes to the pathogenesis of haematological disorders such as multiple myelomas and cutaneous T-cell lymphomas (Annunziata et al., 2007; Keats et al., 2007) . In support for a role of this pathway in lymphomagenesis, NIK is overexpressed in some cases of T-cell leukaemias and in Hodgkin's lymphomas that do not express any oncogenic viral proteins (Saitoh et al., 2008) . Levels of p52 are also increased in those NIK overexpressing haematological disorders and levels of MMP9 are decreased on NIK depletion through RNAi interference in these cells (Saitoh et al., 2008) . Thus, these data, combined with our report, suggest that MMP9 is a direct target gene of the NIK-and p100/p52-dependent signalling cascade.
Coactivators could be recruited by NF-kB/IkB proteins on selected promoters. Indeed, we demonstrated that overproduced p52 induces gene transcription by recruiting selected H3K4 HMT in a promoter-specific manner. Indeed, whereas p52 tethers MLL1 and MLL2 complexes on the MMP9 gene promoter, it failed to do it on the IkBa promoter in NIH3T3 cells. This mechanism may explain why p52 significantly induces MMP9 but not IkBa gene expression in these cells. Our data indeed suggest that the differential recruitment of H3K4 HMT complexes by NF-kB proteins will govern the ability of those target genes to be induced or not by those transcription factors. Several potential mechanisms underlying the recruitment of H3K4 HMT complexes to the target genes were discussed (Ruthenburg et al., 2007) . One hypothesis is the direct recruitment of H3K4 HMT complexes to selected promoters by the DNA binding factors whereas the MLL core complex components (WDR5, RBBP5 and ASH2L) would regulate the activity but not the recruitment of those enzymatic complexes to their target loci. Our data favour this hypothesis as we show here that a Hut-78 mutant that does not generate p52 did not efficiently drive MMP9 gene expression, at least in part because it failed to properly recruit an H3K4me3 enzymatic activity on the promoter of this gene. Our data highlight a promoterspecific recruitment of selected H3K4 HMT complexes by an oncogenic NF-kB/IkB protein, yet the molecular mechanisms underlying this gene-specific effect remains totally unknown. It will be of great interest to experimentally address to which extent the post-translational modifications of the NF-kB/IkB proteins themselves in response to various signals ultimately regulate the ability of those transcription factors to recruit H3K4 HMT complexes on the promoters of their target genes. H3K4 me3 is a dynamic modification (Berger, 2007 ) and a family of proteins sharing the Jumonji C (JmjC) domain were showed to catalyse site-specific demethylation of mono-, di-and trimethylated histones (Klose et al., 2006) . Among them is RBP2, a demethylase that specifically catalyses demethylation on H3K4 (Klose et al., 2007) . Whether this demethylase regulates the expression of the NF-kB target genes remains an open question but our data strongly suggest that the recruitment of NF-kB proteins that positively regulate gene transcription may involve the concomitant removal of H3K4 demethylases from the promoter of those NFkB-dependent genes. Importantly, the H3K27 demethylase Jmjd3 whose inducible expression in lipopolysaccharide-stimulated macrophages is NF-kB dependent was found associated with WDR5 and RBBP5, the core subunits of the H3K4 HMT MLL complexes, a result that support the existence of a functional cross-talk between changes in H3K4me3 and H3K27me3 (De Santa et al., 2007) . This study, combined with our report, opens unexplored avenues of research whose goal will be to define the contribution of those lysinespecific demethylases in the regulation of NF-kB target genes in health and in diseases.
Materials and methods
Cell culture, biological reagents and treatments Human embryonic kidney 293, HeLa and NIH3T3 cells as well as wild-type or NEMO-deficient immortalized mouse embryonic fibroblasts, a gift from Dr M Pasparakis (Institute for Genetics, Centre for Molecular Medicine (CMMC), University of Cologne, Germany), were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS; Life Technologies, Grand Island, NY, USA), glutamine and antibiotics. HUT-78 cells were cultured in RPMI medium supplemented with 10% FCS, glutamine and Recruitment of a H3K4 HMT activity on the MMP9 promoter via p52 and Hut-78. ChIP assays using an anti-H3K4me3 antibody were performed on DNA extracts from NIH3T3 cells infected with the empty pBabe, or the retrovirus expressing p52, Hut-78 or the Hut-78 DGRR mutant. Primers were derived from the promoter region of MMP9 or IkBa genes and were designed to amplify a fragment that includes the kB sites. The recruitment of the H3K4me3 activity in the NIH3T3 cells infected with the empty pBabe construct was set to 1 and its levels in the other conditions were relative to that after normalization with H3. The figure shows the data from three independent experiments performed in duplicates (mean values±s.d.) . (c) Impaired recruitment of the H3K4me3 activity in p52-depleted HUT-78 cells. ChIP assays on HUT-78 cells infected with the indicated shRNA construct were carried out using an antiH3K4me3 antibody. The signal obtained from a noncoding region (downstream of the albumin gene (Kouskouti and Talianidis, 2005) ) was used to compensate for possible fluctuations arising during handling. The H3K4 me3 ChIP values in HUT-78 cells infected with the control shRNA construct was set to 1 and its value in the HUT-78 cells infected with the shRNA p52 was relative to that after normalization with the total H3 signal (as detected using the corresponding anti-H3 antibody). The figure shows the data obtained from five independent experiments performed on two distinct infections (means±s.d.). (d) Association of p52 with ASH2L but not with RBBP5 and WDR5. 293 cells were transfected with the indicated expression plasmids and anti-FLAG immunoprecipitates followed by anti-p100 western blot analysis were carried out on the cell extracts (top panels). Anti-p100 and anti-FLAG western blots were performed on the crude cell extracts as well (bottom panels). (e) Hut-78 but not Hut-78 NLS 1234 colocalizes with ASH2L in the nucleus. HeLa cells were transfected with the indicated expression plasmids and anti-p100 or anti-HA immunofluorescences were carried out to detect Hut-78, Hut-78 NLS 1234 or ASH2L, respectively. (f) Association of Hut-78 with MLL1 and MLL2 in native chromatin-enriched extracts. Chromatin-associated proteins were isolated from highly purified and intact nuclei of HUT-78 cells (40 Â 10 6 cells per experimental condition), as described (Aygun et al., 2008) and anti-HA (negative control), -ASH2L, -MLL1 and -MLL2 immunoprecipitates were carried out from those extracts, using the corresponding antibodies, followed by an anti-p100 western blot (panel on the left, lanes 1-4, respectively). Cell extracts were also subjected to anti-p100 western blot analysis (right panel). (g) Enhanced MLL1 and MLL2 recruitments to the MMP9 but not the IkBa promoter on p52 overexpression in NIH3T3 cells. ChIP assays using an anti-MLL1 or anti-MLL2 antibody were performed on DNA extracts from NIH3T3 cells infected with the empty pBabe, or the retrovirus expressing p52. The recruitment of MLL1 or MLL2 in the NIH3T3 cells infected with the empty pBabe construct was set to 1 and its levels in the other conditions were relative to that after normalization with H3. The Figure shows the data from three (MLL1) or two (MLL2) independent experiments performed in duplicates (mean values±s.d).
Involvement of MLL1 and MLL2 in Hut-78-mediated MMP9 gene induction I Robert et al antibiotics. The lymphoma cell line 164T2, a gift from Dr Y St-Pierre (INRS-Institut Armand-Frappier, University of Que´bec, Laval, Que´bec, Canada), was cultured as described (Aoudjit et al., 1998) . TNFa was from Roche Applied Sciences (Indianapolis, IN, USA) whereas the generation of the LTbR agonistic antibody was previously described (Dejardin et al., 2002) .
Details on expression constructs and antiserum sources are described in Supplementary Data.
Immunoprecipitations, immunofluorescences and isolation of enriched native chromatin extracts Immunoprecipitations in 293 cells were carried out as previously described (Viatour et al., 2003) . For immunofluorescence studies, HeLa cells were seeded in six-well plates and subsequently transfected with the indicated expression plasmids using FUGENE 6 (Roche). Twenty-four hours later, cells were washed with phosphate-buffered saline, fixed with 4% paraformaldehyde and permeabilized with ethanol for 6 min at À20 1C. Fixed cells were incubated with monoclonal anti-p100 antibodies for 45 min at 371C followed by a 45 min incubation at RT with fluorescein isothiocyanate-conjugated anti-mouse immunoglobulin G (Dako, Glostrup, Denmark). Coverslips were then mounted with Prolong Gold Antifade (Invitrogen, Carlsbad, CA, USA) and cells were observed by fluorescent microscopy (Nikon).
Preparation of enriched native chromatin extracts from HUT-78 cells were carried out as described (Aygun et al., 2008) .
Retroviral and lentiviral infections of NIH3T3 and HUT-78 cells
Retroviral infections of NIH3T3 cells were performed as described (Viatour et al., 2004) . For lentiviral infections of HUT-78 cells, 293FT cells were transfected with 12 mg of the 'non-target' lentiviral shRNA plasmid (used as negative control) or the shRNA construct that targets p100/p52 (NM_002502.2) with the following sequence 5 0 -CCGG CCCTATCACAAGATGAAGATTCTCGAGAATCTTCAT CTTGTGATAGGGTTTTT-3 0 and with 12 and 5 mg of R8.91 and VSVG plasmids, respectively. The supernatants from those infected cells were collected 48 h after transfection, added with polybrene to 5 Â 10 5 HUT-78 cells and subjected to centrifugation for 10 min at 1200 r.p.m. This later step was repeated the next day and HUT-78 cells were treated with puromycine (1 mg/ml) 48 h after the last infection.
Zymograms
Conditioned media of cells incubated in serum-free RPMI for 24 or 48 h were collected and centrifuged. Supernatant (18 ml) mixed with 6 ml of loading buffer were applied onto a 10% polyacrylamide gel copolymerized with gelatin (1 mg/ml). After electrophoresis, gels were renatured in 2% Triton X-100 for 1 h and incubated overnight at 37 1C in a buffer consisting of 50 mM Tris-HCl (pH7.6) and 10 mM CaCl 2 . The gels were then stained with Coomassie brilliant blue in 40% methanol and 10% acetic acid and destained in 20% methanol and 10% acetic acid. Gelatinase activities were detected as transparent bands on the blue background.
Matrigel invasion assay
The assay was performed using a 24-well polycarbonate transwell permeable support with 8 mm pores (Corning Costar), coated with 6.21 mg of Matrigel (BD Biosciences, Bedford, MA, USA). HUT-78 cells infected with distinct shRNA constructs were suspended in serum-free RPMI at a concentration of 5.10 5 cells/ml and 100 ml were loaded into top chambers. The lower chambers were filled with 0.6 ml RPMI containing 10% fetal bovine serum. After 72 h of incubation at 37 1C in a humidified 5% CO 2 incubator, cells that migrated through the Matrigel-coated filters were recovered from the lower compartment and counted using a Thoma hemocytometer.
Affymetrix microarray analysis
Total RNAs were extracted from NIH3T3 cells stably infected with empty virus or virus expressing p52 or Hut-78 and cultured in triplicates, using the RNeasy Minit kit from Qiagen (Valencia, CA, USA). The integrity of the RNAs from those nine distinct experimental conditions was checked with the Agilent Bioanalyzer using the RNA 6000 Nano kit (Agilent, Santa Clara, CA, USA). Biotin-labelled cRNA and subsequent hybridization and scanning were performed following the manufacturer's instructions.
Real-Time PCRs and ChIP assays
Total RNAs were extracted using the EZNA Total RNA kit (Omega Bio-tek, Norcross, GA, USA) and cDNAs were synthesized using the RevertAid H Minus First Strand cDNA Synthesis kit (Fermentas, Glen Burnie, MD, USA). Subsequent PCRs were carried out using the Power SYBR Green PCR master kit (Applied Biosystems, Foster City, CA, USA) on the LightCycler 480 (Roche). Primers to amplify IkBa and MMP9 sequences from NIH3T3 and HUT-78 cells as well as for the amplification of glyceraldehyde-3-phosphate dehydrogenase and 18S sequences (for normalization purposes in NIH3T3 and HUT-78 cells, respectively) are available on request.
For ChIP assays, cells were cross-linked with 1% paraformaldehyde and sonicated using the Bioruptor (Diagenode). ChIP assays were performed using the OneDay ChIP kit (Diagenode) using 1.5-2 Â 10 6 cells per experimental condition. Subsequent PCRs were carried out using the Power SYBR Green PCR master kit (Applied Biosystems) on the LightCycler 480 (Roche). Input DNA was analysed simultaneously and used as normalization. For normalization of the ChIP assays in HUT-78 cells, the signal obtained from a non-coding region (downstream of the albumin gene (Kouskouti and Talianidis, 2005 ) was used to compensate for possible fluctuations arising during handling. For the histone-related ChIPs, H3K4me3 ChIP values were normalized according to the total H3 signal (as detected using the corresponding anti-H3 antibody).
